GIVING WOMEN THE POWER TO SAFEGUARD THEIR OWN HEALTH.
Women in developing countries bear the greatest burden of poor health. Key to addressing this inequity: access to solutions for the growing threat of noncommunicable diseases (NCDs)—cervical, breast, and other woman-related cancers; diabetes; and heart disease—and access to options that empower women to choose when and whether to have children.
PATH is doubling down on our work in women’s health, prioritizing women’s cancers and building on that foundation to intercept other NCDs early on. And we’re applying decades of experience to increase access to family planning, giving women the power to build healthier futures for themselves and their children.
WHAT YOU NEED TO KNOW
- Nearly 225 million women want to prevent pregnancy but can’t access family planning.
- If those women had access to family planning, it would reduce unintended pregnancy by 70 percent, unsafe abortion by 74 percent, and pregnancy-related death by 66 percent.
- Smaller family sizes mean healthier children and a better shot at a bright economic future.
- Noncommunicable diseases—like women’s cancers, heart disease, and diabetes—are the single greatest cause of sickness and death in low-resource settings.
- A single member with a noncommunicable disease can throw a family into poverty.
- Half a million women are diagnosed with cervical cancer every year; an estimated 275,000 die from it.
- Breast cancer will afflict nearly 9.1 million women in developing countries over the next decade.
- November 2016: Nearly 500,000 doses of the injectable contraceptive Sayana® Press were administered to women in Burkina Faso, Niger, Senegal, and Uganda. About 120,000 of the women were using modern contraception for the first time.
- June 2016: We expanded access to two contraceptives, with more than 400,000 doses of the injectable contraceptive Sayana® Press administered in four African countries and the one-size-fits-most Caya® diaphragm available in more than 25 countries.
- February 2016: The Woman's Condom achieved prequalification by the World Health Organization and the United Nations Population Fund, paving the way for increased access worldwide.
- June 2015: Safe and effective, the one-size-fits-most Caya® diaphragm has been introduced in more than 15 countries.
- June 2015: The injectable contraceptive Sayana® Press is now in four countries.
- May 2015: A fast and cost-effective DNA test for the primary cause of cervical cancer launched in Guatemala, allowing women to collect their own screening samples.
Photo: PATH/Gabe Bienczycki